Johnson & Johnson (JNJ) — Free Cash Flow Yield
Healthcare
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
| Metric | Value |
|---|---|
| FCF Yield | 3.1% |
| Healthcare Sector Avg FCF Yield | 4.9% |
| Annual Free Cash Flow | $19.3B |
| Market Cap | $627.4B |
| P/E Ratio | 30.2x |
Johnson & Johnson's FCF yield of 3.1% is below the Healthcare sector average (4.9%).
Frequently Asked Questions
What is Johnson & Johnson's (JNJ) free cash flow yield?
Johnson & Johnson's (JNJ) free cash flow yield is 3.1%. That is below the Healthcare sector average (4.9%).
Is JNJ's free cash flow yield good?
At 3.1%, JNJ's free cash flow yield is considered weak — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.
How much free cash flow does Johnson & Johnson generate?
Johnson & Johnson generated $19.3B in free cash flow, against a market cap of $627.4B.
How is free cash flow yield calculated?
Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.
Data from public filings. Not investment advice. Calculate your own FCF yield →